Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant

TP53 gene deletion is associated with poor outcomes in multiple myeloma (MM). We report the outcomes of patients with MM with and without TP53 deletion who underwent immunomodulatory drug (IMiD) and/or proteasome inhibitor (PI) induction followed by autologous hematopoietic stem cell transplant (aut...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Gaballa, Sameh, Saliba, Rima M., Srour, Samer, Lu, Gary, Brammer, Jonathan E, Shah, Nina, Bashir, Qaiser, Patel, Krina, Bock, Fabian, Parmar, Simrit, Hosing, Chitra, Popat, Uday, Delgado, Ruby, Rondon, Gabriela, Shah, Jatin J., Manasanch, Elisabet E., Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031524/
https://ncbi.nlm.nih.gov/pubmed/27420405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados